Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.2350 (-1.4%) ($4.2350 - $4.2350) on Tue. Sep. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.74% (three month average) | RSI | 35 | Latest Price | $4.2350(-1.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) SPLV(91%) IBB(83%) SDY(73%) IWD(66%) JETS(66%) | Factors Impacting ATRA price | ATRA will decline at least -5.37% in a week (0% probabilities). OIH(-36%) UUP(-32%) USO(-26%) EWY(-7%) TBT(-38%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.37% (StdDev 10.74%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $4.52 | 5 Day Moving Average | $4.18(1.32%) | 10 Day Moving Average | $4.23(0.12%) | 20 Day Moving Average | $4.52(-6.31%) | To recent high | -51.8% | To recent low | 48.3% | Market Cap | $315m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |